Prometheus Dooms DNA Analysis Patent, Merial Claims

Law360, New York (May 2, 2012, 6:24 PM EDT) -- A patent held by Genetic Technologies Ltd. on a method of using DNA in genetic analysis should be invalidated in light of the U.S. Supreme Court's recent Prometheus ruling, Sanofi-Aventis SA's animal health unit Merial Ltd. said in a re-examination request filed Monday.

Merial, one of several companies Australia-based Genetic Technologies has sued over the patent, told the U.S. Patent and Trademark Office that the patent contains claims akin to those the high court found to be unpatentable laws of nature under Section 101 of the...
To view the full article, register now.